9 completed, 1 terminated. 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 9, Terminated 1 |
Follow Stage IVB Cervical Cancer: new trials by email Literature Review of Stage IVB Cervical Cancer trials Research Report on Stage IVB Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer Camrelizumab, Apatinib, Paclitaxel - Stage IVB Cervical Cancer, Recurrent Cervical Cancer | Phase 2 | Terminated | Sun Yat-Sen University Cancer Center | 35 | 2021-07-30 | 2026-07-29 |
| Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer eribulin mesylate - Recurrent Cervical Cancer, Stage IIIA Cervical Cancer | Phase 2 | Completed | University of Southern California | 32 | 2012-08-09 | 2025-11-06 |
| Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer Filgrastim, Laboratory Biomarker Analysis, Pegfilgrastim - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 27 | 2011-02-01 | 2019-08-08 |
| Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery Temsirolimus, Laboratory Biomarker Analysis - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 38 | 2009-12-01 | 2015-09-10 |
| Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer triapine, cisplatin, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Vaginal Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 26 | 2009-07-01 | 2017-11-17 |
| Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 50 | 2009-05-01 | 2013-11-28 |
| FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer 18F-fluoromisonidazole, fluorodeoxyglucose F 18, positron emission tomography - Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 16 | 2007-11-01 | 2016-12-30 |
| Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery sunitinib malate - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 19 | 2007-01-01 | 2015-02-16 |
| EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer EF5 - Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 60 | 2005-02-01 | 2013-01-16 |
| Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer Paclitaxel, Oxaliplatin - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 35 | 2003-01-01 | 2015-11-17 |
Uterine Cervical Neoplasms (10) · Carcinoma, Ovarian Epithelial (2) · Endometrial Neoplasms (2) · Vaginal Neoplasms (2) · Fallopian Tube Neoplasms (1) · Vulvar Neoplasms (1)
Female Urogenital Diseases (10) · Female Urogenital Diseases and Pregnancy Complications (10) · Genital Diseases (10) · Genital Diseases, Female (10) · Genital Neoplasms, Female (10) · Neoplasms (10) · Neoplasms by Site (10) · Urogenital Diseases (10) · Urogenital Neoplasms (10) · Uterine Cervical Diseases (10) · Uterine Diseases (10) · Uterine Neoplasms (10) · Adnexal Diseases (2) · Carcinoma (2) · Endocrine Gland Neoplasms (2)
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (2) · Cisplatin (2) · Fluorodeoxyglucose F18 (2) · Magnetic Resonance Spectroscopy (2) · Paclitaxel (2) · 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1) · Bevacizumab (1) · Carboplatin (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Oxaliplatin (1) · Radiosurgery (1) · Sunitinib (1) · Taxes (1) · Topotecan (1)
National Cancer Institute (NCI) (7) · Case Comprehensive Cancer Center (1) · Sun Yat-Sen University Cancer Center (1) · University of Southern California (1)
United States (7) · Canada (2) · China (1)
Charles Kunos (2) · Anna Tinker (1) · Christina Chu (1) · Dennis Kuo (1) · Helen Mackay (1) · Joseph Rajendran (1) · Lynda Roman, MD (1) · Robert DeBernardo, MD (1) · Xin Huang, MD (1)
PMID 19931137, PMID 22105720, PMID 36185311
N01CM37008 (1), N01CM62204 (1), P30CA013330 (1), P30CA043703 (1), R21CA099346 (1), U01CA062502 (1), U10CA027469 (1), U10CA180868 (1)